文献速递类风湿关节炎

DNA甲基转移酶抑制剂5'-阿扎胞苷改善小鼠自身免疫性关节炎

Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine.
PubMed 文献 · Arthritis Rheumatol · 2019-06-18

本研究在蛋白聚糖诱导关节炎(PGIA)小鼠模型中评估DNA甲基转移酶抑制剂5'-阿扎胞苷(5'-azaC)的治疗潜力。5'-azaC通过去甲基化表观遗传失活的Ahr基因,抑制Aicda基因表达、减少类别转换重组和生发中心形成,最终降低IgG1抗体产生并改善自身免疫性关节炎。

要点

  • 5'-azaC在PGIA小鼠中通过去甲基化Ahr基因抑制Aicda表达,减少类别转换重组。
  • 5'-azaC处理损害生发中心形成并降低血清IgG1抗体水平。
  • DNA高甲基化在自身免疫性关节炎发病中起主导作用,靶向抑制具有治疗潜力。

核心结论

  • DNA高甲基化在自身免疫性关节炎发病中起主导作用,其靶向抑制具有治疗潜力。

研究设计与样本

  • 研究在关节炎B细胞中用甲基化CpG岛恢复分析-染色质免疫沉淀(ChIP)探索疾病相关全基因组DNA甲基化谱。
  • 蛋白聚糖诱导关节炎(PGIA)小鼠接受5'-azaC治疗,通过ELISA测血清IgM和IgG1抗体、实时定量PCR测类别转换重组效率和Aicda基因表达、免疫组化监测生发中心形成、流式细胞术确定B细胞亚群变化。
  • 用RNA干扰、ChIP和荧光素酶试验探索5'-azaC诱导的Aicda基因调控。

主要发现

  • 探索了小鼠B细胞中关节炎相关高甲基化区域,证明DNA去甲基化对自身免疫性关节炎有有益作用。
  • 5'-azaC介导的表观遗传失活Ahr基因去甲基化导致Aicda基因表达受抑、类别转换重组减少和生发中心形成受损。
  • 该过程最终导致IgG1抗体产生减少和小鼠自身免疫性关节炎改善。

临床怎么用

  • DNA甲基转移酶抑制剂可能作为自身免疫性关节炎的潜在治疗策略,通过表观遗传调控B细胞功能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Disease-associated, differentially hypermethylated regions have been reported in rheumatoid arthritis (RA), but no DNA methyltransferase inhibitors have been evaluated in either RA or any animal models of RA. The present study was conducted to evaluate the therapeutic potential of 5'-azacytidine (5'-azaC), a DNA methyltransferase inhibitor, and explore the cellular and gene regulatory networks involved in the context of autoimmune arthritis. METHODS: A disease-associated genome-wide DNA methylation profile was explored by methylated CpG island recovery assay-chromatin immunoprecipitation (ChIP) in arthritic B cells. Mice with proteoglycan-induced arthritis (PGIA) were treated with 5'-azaC. The effect of 5'-azaC on the pathogenesis of PGIA was explored by measuring serum IgM and IgG1 antibody levels using enzyme-linked immunosorbent assay, investigating the efficiency of class-switch recombination (CSR) and Aicda gene expression using real-time quantitative polymerase chain reaction, monitoring germinal center (GC) formation by immunohistochemistry, and determining alterations in B cell subpopulations by flow cytometry. The 5'-azaC-induced regulation of the Aicda gene was explored using RNA interference, ChIP, and luciferase assays. RESULTS: We explored arthritis-associated hypermethylated regions in mouse B cells and demonstrated that DNA demethylation had a beneficial effect on autoimmune arthritis. The 5'-azaC-mediated demethylation of the epigenetically inactivated Ahr gene resulted in suppressed expression of the Aicda gene, reduced CSR, and compromised GC formation. Ultimately, this process led to diminished IgG1 antibody production and amelioration of autoimmune arthritis in mice. CONCLUSION: DNA hypermethylation plays a leading role in the pathogenesis of autoimmune arthritis and its targeted inhibition has therapeutic potential in arthritis management.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Tóth DM, Ocskó T, Balog A, et al. Amelioration of Autoimmune Arthritis in Mice Treated With the DNA Methyltransferase Inhibitor 5'-Azacytidine. Arthritis Rheumatol. 2019. PMID: 30835944. doi:10.1002/art.40877

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。